SCHEMBL6137318

SCHEMBL6137318

CC(C)(C)OC(=O)N1C(=O)C2CCCC2c2cc(Br)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.42
GABRA1 P14867 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRA4 P48169 1/20 0.39
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
BACE1 P56817 4/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
USP30 Q70CQ3 3/20 0.36
FPR2 P25090 4/20 0.36
GABRB2 P47870 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137803 0.86 ALDH1A1 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6137592 0.83 BCHE (0.47) CDK1ALDH1A1KMT2ABCHEUCHL1
SCHEMBL30847702 0.82 CDK1 (0.45) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL25994275 0.82 CDK1 (0.45) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL31693980 0.79 BACE1 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL13949555 0.76 CREBBP (0.49) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL23959057 0.76 CDK1 (0.46) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL6137319 0.74 HRH3 (0.37) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL6137764 0.73 GPR119 (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6137336 0.72 GPR119 (0.37) TSHRKMT2ANOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed
EP-1129077-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
WO-2000029381-A1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed